Community-acquired pneumonia - which patients are hospitalised?

Citation
Sp. Stauble et al., Community-acquired pneumonia - which patients are hospitalised?, SWISS MED W, 131(13-14), 2001, pp. 188-192
Citations number
13
Categorie Soggetti
General & Internal Medicine
Journal title
SWISS MEDICAL WEEKLY
ISSN journal
14247860 → ACNP
Volume
131
Issue
13-14
Year of publication
2001
Pages
188 - 192
Database
ISI
SICI code
1424-7860(20010407)131:13-14<188:CP-WPA>2.0.ZU;2-V
Abstract
Background and objective: Patients with community-acquired pneumonia can be allocated into low and high-risk mortality groups by simple clinical crite ria. We studied the value of the stratification for outcome as proposed by Fine, et al. to guide the decision for in-hospital versus outpatient treatment i n the emergency department. Patients and methods: We studied demographic data, risk group stratificatio n and decision-making for in-hospital versus outpatient treatment in 101 co nsecutive medical emergency department patients with community-acquired pne umonia. We also analysed predictive factors for hospitalisation of low-risk patients. We obtained complete 30 day follow-up information. Results: Forty-three of 44 high-risk patients were hospitalised after medic al emergency department triage. Twenty-seven (47%) of 57 low-risk patients were hospitalised as well. Based on routine clinical assessment, hospitalis ation of low-risk patients was required for poor medical condition or sever e pneumonia (67%), for lack of social support (15%) and for relevant comorb idity (18%). In an univariate analysis, age (p = 0.003), C-reactive protein (p = 0.0006), presence of comorbidity (p = 0.0001), Charlson index (p = 0. 0001) and active oral steroid treatment (p = 0.028) were significantly corr elated with hospitalisation of low-risk patients. The 30-day mortality rate was 32% in patients allocated to the high-risk gr oup at the time of diagnosis in the emergency department, compared to 0% in low-risk patients. Conclusions: Simple clinical criteria distinguish well between low and high 30-day-mortality risk in patients diagnosed with community-acquired pneumo nia. Nevertheless, 47% of low-risk patients require in-hospital treatment. Age, C-reactive protein, presence of comorbidity and steroid treatment are significantly correlated with hospitalisation of low-risk patients with com munity-acquired pneumonia.